H
688581
vs
S
Shanghai Composite
Over the past 12 months, Hangzhou AGS MedTech Co Ltd has underperformed Shanghai Composite, delivering a return of +5% compared to the Shanghai Composite's +28% growth.
Stocks Performance
688581 vs Shanghai Composite
Performance Gap
688581 vs Shanghai Composite
Performance By Year
688581 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Hangzhou AGS MedTech Co Ltd
Glance View
Hangzhou AGS MedTech Co., Ltd. engages in the research and development, manufacture, and sale of equipment in minimally invasive diagnosis and treat. The company is headquartered in Hangzhou, Zhejiang and currently employs 501 full-time employees. The company went IPO on 2023-05-19. The firm's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.
